Neuland Laboratories (NSE:NEULANDLAB) Long-Term Capital Lease Obligation : ₹92 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Neuland Laboratories Long-Term Capital Lease Obligation?

Neuland Laboratories's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹92 Mil.

Neuland Laboratories's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₹24 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹92 Mil).

Neuland Laboratories's annual Long-Term Capital Lease Obligation declined from Mar. 2022 (₹69 Mil) to Mar. 2023 (₹38 Mil) but then increased from Mar. 2023 (₹38 Mil) to Mar. 2024 (₹92 Mil).

Neuland Laboratories Long-Term Capital Lease Obligation Historical Data

The historical data trend for Neuland Laboratories's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories Long-Term Capital Lease Obligation Chart

Neuland Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

25.78

95.86

69.40

38.48

92.03

Neuland Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															38.48	-	23.54	-	92.03

Neuland Laboratories (NSE:NEULANDLAB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Neuland Laboratories Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuland Laboratories (NSE:NEULANDLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (NSE:NEULANDLAB) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

524558:India

Address

Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033

Website

https://www.neulandlabs.com

Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (NSE:NEULANDLAB) Headlines

No Headlines